Resolute Science, Inc. is a pre-clinical life science company aiming to develop a safe, effective, and novel therapeutic for the treatment of solid tumors.
Subscribe to see Resolute Science, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Resolute Science, Inc. is a life sciences (therapeutics) company headquartered in San Diego, United States. It has raised at least $3.2M across the 2 funding rounds on record. Its most recent funding round raised $2.9M in February 2025. Xcout tracks 9 named people at Resolute Science, Inc., including Andre Basbaum (President & CEO Board Director).
As of 16 November 2026. Source: Xcout Intel.
3 more named people on record for Resolute Science, Inc., with roles, board committees and tenure — see the full roster →
At least $3.2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2.9M | — | |
| SEC Form D filing | $250,000 | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Resolute Science, Inc.'s closest competitors — see the full list of competitors and alternatives →
iOncologi, Inc. is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of intractable solid tumors.
Resonant Therapeutics, Inc. is a biotechnology company headquartered in Houston, Texas, focused on cancer therapeutic discovery based on unique insights.
Vivace Therapeutics, Inc. is a biotechnology research and small molecule discovery company located in San Mateo, California, dedicated to developing first-in-class cancer therapeutics.
Cytosolix, Inc. is a privately held biotechnology research company based in Connecticut that utilizes a small molecule platform for targeted drug delivery to tumors.
Kortuc Inc. develops cancer radiotherapy solutions, specifically offering an innovative radiosensitizer designed to eliminate tumor hypoxia and maximize the effectiveness of radiation treatment. The company serves the medical and oncology research sectors by advancing clinical trials and expanding treatment options for cancer patients.
Persevere Therapeutics, Inc. is a Delaware-incorporated, clinical-stage oncology company based in Chesterbrook, Pennsylvania, developing misetionamide as a first-in-class cancer therapeutic.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Resolute Science, Inc.? Suggest a correction · Work at Resolute Science, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.